The C-terminally encoded, MHC class II-restricted T cell antigenicity of the helicobacter pylori virulence factor CagA promotes gastric preneoplasia

Autor: Anne Müller, Else Marie Agger, Iris Hitzler, Daniela B. Engler, Mathias Oertli, Isabelle C. Arnold
Přispěvatelé: University of Zurich, Müller, Anne
Jazyk: angličtina
Rok vydání: 2011
Předmět:
Adoptive cell transfer
Receptors
Antigen
T-Cell
alpha-beta

T-Lymphocytes
Epitopes
T-Lymphocyte

Epitope
Mice
0302 clinical medicine
Immunology and Allergy
Mice
Knockout

0303 health sciences
biology
Virulence
10061 Institute of Molecular Cancer Research
Adoptive Transfer
3. Good health
medicine.anatomical_structure
Bacterial Vaccines
Host-Pathogen Interactions
2723 Immunology and Allergy
T cell
Immunology
Helicobacter Infections
03 medical and health sciences
Antigen
Bacterial Proteins
Stomach Neoplasms
MHC class I
medicine
CagA
Animals
Humans
Secretion
030304 developmental biology
Antigens
Bacterial

2403 Immunology
Helicobacter pylori
Histocompatibility Antigens Class II
Th1 Cells
biology.organism_classification
bacterial infections and mycoses
Virology
digestive system diseases
Mice
Inbred C57BL

Animals
Newborn

Gastric Mucosa
biology.protein
570 Life sciences
Immunization
030215 immunology
Zdroj: Journal of immunology (Baltimore Md. : 1950)
Popis: Chronic infection with the human bacterial pathogen Helicobacter pylori causes gastritis and predisposes carriers to an increased gastric cancer risk. Consequently, H. pylori-specific vaccination is widely viewed as a promising strategy of gastric cancer prevention. H. pylori strains harboring the Cag pathogenicity island (PAI) are associated with particularly unfavorable disease outcomes in humans and experimental rodent models. We show in this study using a C57BL/6 mouse model of Cag-PAI+ H. pylori infection that the only known protein substrate of the Cag-PAI–encoded type IV secretion system, the cytotoxin-associated gene A (CagA) protein, harbors MHC class II-restricted T cell epitopes. Several distinct nonoverlapping epitopes in CagA’s central and C-terminal regions were predicted in silico and could be confirmed experimentally. CagA+ infection elicits CD4+ T cell responses in mice, which are strongly enhanced by prior mucosal or parenteral vaccination with recombinant CagA. The adoptive transfer of CagA-specific T cells to T cell-deficient, H. pylori-infected recipients is sufficient to induce the full range of preneoplastic immunopathology. Similarly, immunization with a cholera toxin-adjuvanted, CagA+ whole-cell sonicate vaccine sensitizes mice to, rather than protects them from, H. pylori-associated gastric cancer precursor lesions. In contrast, H. pylori-specific tolerization by neonatal administration of H. pylori sonicate in conjunction with a CD40L-neutralizing Ab prevents H. pylori-specific, pathogenic T cell responses and gastric immunopathology. We conclude that active tolerization may be superior to vaccination strategies in gastric cancer prevention.
Databáze: OpenAIRE